Adenosine Deaminase Deficiency: Unanticipated Benefits from the Study of a Rare Immunodeficiency

被引：14

作者：

Blackburn, Michael R. ^{[2
]}

Thompson, Linda F. ^{[1
]}

机构：

[1] Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA

[2] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA

来源：

JOURNAL OF IMMUNOLOGY | 2012年 / 188卷 / 03期

关键词：

NUCLEOSIDE-PHOSPHORYLASE DEFICIENCY; GENE-THERAPY; MICE; DISEASE; CONSEQUENCES; PULMONARY; IMMUNITY; EXHIBIT; PATIENT;

D O I：

10.4049/jimmunol.1103519

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：933 / 935

页数：3

共 24 条

[1] Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency. [J].

Aiuti, Alessandro ;

Cattaneo, Federica ;

Galimberti, Stefania ;

Benninghoff, Ulrike ;

Cassani, Barbara ;

Callegaro, Luciano ;

Scaramuzza, Samantha ;

Andolfi, Grazia ;

Mirolo, Massimiliano ;

Brigida, Immacolata ;

Tabucchi, Antonella ;

Carlucci, Filippo ;

Eibl, Martha ;

Aker, Memet ;

Slavin, Shimon ;

Al-Mousa, Hamoud ;

Al Ghonaium, Abdulaziz ;

Ferster, Alina ;

Duppenthaler, Andrea ;

Notarangelo, Luigi ;

Wintergerst, Uwe ;

Buckley, Rebecca H. ;

Bregni, Marco ;

Marktel, Sarah ;

Valsecchi, Maria Grazia ;

Rossi, Paolo ;

Ciceri, Fabio ;

Miniero, Roberto ;

Bordignon, Claudio ;

Roncarolo, Maria-Grazia .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (05) :447-458

[2] The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice - Differential impact on pulmonary and immunologic abnormalities [J].

Blackburn, MR ;

Aldrich, M ;

Volmer, JB ;

Chen, W ;

Zhong, HY ;

Kelly, S ;

Hershfield, MS ;

Datta, SK ;

Kellems, RE .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (41) :32114-32121

[3] Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction [J].

Blackburn, MR ;

Volmer, JB ;

Thrasher, JL ;

Zhong, HY ;

Crosby, JR ;

Lee, JJ ;

Kellems, RE .

JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (02) :159-170

[4] Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency [J].

Blackburn, MR ;

Datta, SK ;

Kellems, RE .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (09) :5093-5100

[5] LYMPHO-SPECIFIC TOXICITY IN ADENOSINE-DEAMINASE DEFICIENCY AND PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY - POSSIBLE ROLE OF NUCLEOSIDE KINASE(S) [J].

CARSON, DA ;

KAYE, J ;

SEEGMILLER, JE .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (12) :5677-5681

[6] Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease [J].

Cavazzana-Calvo, M ;

Hacein-Bey, S ;

Basile, CD ;

Gross, F ;

Yvon, E ;

Nusbaum, P ;

Selz, F ;

Hue, C ;

Certain, S ;

Casanova, JL ;

Bousso, P ;

Le Deist, F ;

Fischer, A .

SCIENCE, 2000, 288 (5466) :669-672

[7] DEOXYADENOSINE TRIPHOSPHATE AS A POTENTIALLY TOXIC METABOLITE IN ADENOSINE-DEAMINASE DEFICIENCY [J].

COHEN, A ;

HIRSCHHORN, R ;

HOROWITZ, SD ;

RUBINSTEIN, A ;

POLMAR, SH ;

HONG, R ;

MARTIN, DW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (01) :472-476

[8]

COLEMAN MS, 1978, J BIOL CHEM, V253, P1619

[9]

Gessi S, 2011, ADV PHARMACOL, V61, P41, DOI 10.1016/B978-0-12-385526-8.00002-3

[10]

GIBLETT ER, 1972, LANCET, V2, P1067

← 1 2 3 →